噬血细胞综合症2例并文献复习作者杨宝忠.ppt_第1页
噬血细胞综合症2例并文献复习作者杨宝忠.ppt_第2页
噬血细胞综合症2例并文献复习作者杨宝忠.ppt_第3页
噬血细胞综合症2例并文献复习作者杨宝忠.ppt_第4页
噬血细胞综合症2例并文献复习作者杨宝忠.ppt_第5页
已阅读5页,还剩52页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

噬血细胞综合症,hemophagocyticsyndrome2例报告并最新文献复习,杨保忠执笔2011-11-9,病例1:女性,22岁。间断发热伴关节痛、皮疹28天入院。查体:T:38.1,P:88次/分,R:18次/分,BP:100/60mmHg。神清语利,查体合作。全身皮肤黏膜未见黄染、蜘蛛痣及瘀点瘀斑,颈部两侧可触及皮下结节,活动度可,无压痛。眼结膜无充血、苍白,巩膜无黄染。颈静脉无怒张,双肺呼吸音清,未闻及干湿性啰音。心音有力,心率88次/分,律齐,各瓣膜未闻及病理性杂音。腹平,未见腹壁静脉曲张,未见胃肠型蠕动波;腹软,无压痛、反跳痛及肌紧张,肝脾未触及明显肿大,Murphy征阴性;肝区叩击痛阴性,移动性浊音阴性;肠鸣音正常存在。双下肢无水肿。生理反射存在,病理征未引出。左侧足背部可见一约3cm*3cm红斑。,血常规示:WBC20.6109/LRBC:3.531012/LHGB:93g/LW-LCR0.829C反应蛋白(2011-5-31北京XX医院)42g/L。风湿三项(2011-6-7XX总医院):ASO296IU/mlRF3000g/dL),orsCD25significantlyaboveage-adjustednormalranges,generallypromptustopursueacompleteHLHdiagnosticevaluation,LiverdiseaseandcoagulopathyMostpatientshavevariableevidenceofhepatitisatpresentation.HLHshouldbeconsideredinthedifferentialdiagnosisofacuteliverfailure,especiallyiflymphocyticinfiltratesarenotedonbiopsy.Autopsyevaluationoftheliverhasshownchronicpersistenthepatitiswithperiportallymphocyticinfiltrationin22of27patientswithHLH.52NeonateswithHLHmaypresentwithhydropsfetalisandliverfailure.53Veno-occlusivediseasemayarisespontaneouslyinpatientswithHLH,andratesofveno-occlusivediseaseashighas25%arereportedafterbonemarrowtransplantation.54Nearly95%ofpatientshavefeaturesofdisseminatedintravascularcoagulationandareathighriskforacutebleeding.49Furthermore,patientswithHLHresultingfromdegranulationdefectsmaymanifestplateletdysfunction.55,BonemarrowfailureAnemiaandthrombocytopeniaoccurin80%ofpatientsatthetimeofpresentationwithHLH.49,51Thecellularityofbonemarrowaspiratesvariesfromnormocelluartohypocellularorhypercellular.Prevalenceofhemophagocytosis(examplesinFigure4)inassociationwithHLHdiagnosisrangesfrom25%-100%,with1-10hemophagocytesper500cellsincasesreportedaspositive.9AlthoughhemophagocytosisinbonemarrowisassociatedwithHLH,themorphologicphenomenonmayalsobeinducedbymorecommonevents,includingbloodtransfusions,infection,autoimmunedisease,andotherformsofbonemarrowfailureorcausesofredbloodcelldestruction.5658DespitethenomenclatureofHLH,diagnosisshouldneverbemadeorexcludedsolelyonthepresenceorabsenceofhemophagocytosis.Infiltrationofbonemarroworliverbyactivatedmacrophages,alongwithglobalclinicalevaluation,maydistinguishHLHfromothercausesofhemophagocytosis.,Hemophagocytosisonbonemarrowaspirateandbiopsy.(A)Twoexamplesofmacrophagesidentifiedonbonemarrowaspiration(Wright-Giemsastain).(B)CD163stainingofbonemarrowbiopsysectionhighlightshemophagocytosis(counterstainedwithhematoxylin).ImagesweretakenonaNikonElipsemicroscope(panelA:100/10;panelB:20/10)withoutoil,withaSpotdigitalcamera.Imagesareunmanipulated.CourtesyofDrJunMo.,SkinmanifestationsPatientsmayhaveavarietyofskinmanifestations,includinggeneralizedmaculopapularerythematousrashes,generalizederythroderma,edema,panniculitis,morbilliformerythema,petechiae,andpurpura.1,59Theincidenceofskinmanifestationsrangesfrom6%-65%inpublishedserieswithhighlypleomorphicpresentations.50,60,61SomepatientsmaypresentwithfeaturessuggestiveofKawasakidisease,includingerythematousrashes,conjunctivitis,redlips,andenlargedcervicallymphnodes.62Rashesmaycorrelatewithlymphocyteinfiltrationonskinbiopsy,andhemophagocytosismayalsobefound.,PulmonarydysfunctionPatientsmaydeveloppulmonarydysfunctionthatleadstourgentadmissiontotheintensivecareunit.Inareviewoftheradiographicabnormalitiesin25patients,17hadacuterespiratoryfailurewithalveolarorinterstitialopacities,withfataloutcomesin88%ofthosecases.WorseningpulmonaryfunctionisanominoussignandshouldsuggestinadequatecontrolofHLHand/orinfection.63,Brain,ophthalmic,andneuromuscularsymptomsMorethanone-thirdofpatientswillpresentwithneurologicsymptoms,includingseizures,meningismus,decreasedlevelofconsciousness,cranialnervepalsy,psychomotorretardation,ataxia,irritability,orhypotonia.64Thecerebrospinalfluid(CSF)isabnormalin50%ofHLHpatientswithfindingsofpleocytosis,elevatedprotein,and/orhemophagocytosis.64MRIfindingsarevariable,includingdiscretelesions,leptomeningealenhancement,orglobaledema,andimagescorrelatewithneurologicsymptoms.65Retinalhemorrhages,swellingoftheopticnerve,andinfiltrationofthechoroidhavebeenreportedininfantswithHLH.6668Diffuseperipheralneuropathywithpainandweaknesssecondarytomyelindestructionbymacrophagesmayalsooccur.69,70,嗜红细胞综合征的治疗:,TreatingHLHWithouttherapy,survivalofpatientswithactivefamilialHLHis2months.60,61ThefirstinternationaltreatmentprotocolforHLHwasorganizedbytheHistiocyteSocietyin1994andledtoreportedsurvivalof55%,withamedianfollow-upof3.1years.71TheHLH-94protocol,asillustratedinFigure5,includedan8-weekinductiontherapywithdexamethasone,etoposide,andintrathecalmethotrexate.Theprincipalgoalofinductiontherapyistosuppressthelife-threateninginflammatoryprocessthatunderliesHLH.Attheendof8weeks,patientsareeitherweanedoffoftherapyortransitionedtocontinuationtherapy,whichisintendedonlyasabridgetotransplantation.,家族性噬血细胞综合征a.化学疗法:常用的化疗药物有细胞毒性药物,如长青花碱或长春新碱与肾上腺皮质激素联用,亦可应用反复的血浆置换,或VP16或VM26与肾上腺皮质激素合用。有的应用VP16、肾上腺皮质激素,鞘内注射氨甲煤呤(MTX)及头颅照射治疗取得良好效果。有的主张在缓解时,应用上述药物小剂量维持治疗。,b.免疫治疗:有人用环胞菌素A治疗家族性HPS取得满意效果,同样,用抗胸腺细胞球蛋白(ATG)亦可诱导缓解。,c.造血干细胞移植:尽管上述化疗可使病情缓解,有的可缓解9年,但仍不能根治家族性HPS。Fisher等(1986)首先报告用骨髓移植治愈家族性HSP患者,在2000年上海举行的国际小儿血液肿瘤学术研讨会上,日本学者Imashukn报告5例由EBV所致的HPS,应用造血干细胞移植,随后用环胞菌素A加VP16,大大改善了本病的预后。,d.治疗方案:国际组织细胞协会1994年提出一个治疗家族性HPS的方案(HLH94):地塞米松每日10mg/m2与VP16每周150mg/m2,连用3周,第4周起减量,第9周起VP16每2周用药1次,并加用环胞菌素A每日56mg/kg口服,共用1年。有神经症状者,前8周每2周鞘内注射MTX1次。如果是家族性HPS,争取做异基因造血干细胞移植。如果为非家族性HPS,则在8周治疗后根据病情停止治疗。,原发性HPS或病因不明未检出明显潜在疾患者除加强支持治疗和并发症的治疗外,目前尚无特效治疗,根本性治疗是同种异体造血干细胞移植。继发性HPS应作病因探索,治疗应以基础病与HPS并重。,继发性噬血细胞综合征,继发性HPS针对病因进行相应治疗。对HPS或高细胞因子血症的治疗对策为:类固醇疗法或大剂量甲基强的松龙冲击;静脉滴注大剂量丙种球蛋白(多用于VAHS);抑制T细胞活化的特异性抑制剂环孢菌素A或联用G-CSF治疗VAHS,或抗胸腺细胞球蛋白;,直接拮抗细胞因子的抗TNF抗体和IL-1受体拮抗剂;为抑制或减少淋巴因子的供应源可采用化疗。包括CHOP、CHOPE方案或缓慢静滴长春新碱。屡已报道应用依托泊甙(VP16)治疗原因不明的重症HPS、EBV-AHS或LAHS奏效。预后分析表明,对于不易与MH鉴别的HPS患者启用化疗是必需的;骨髓扫荡性(根治性)治疗和异基因骨髓移植(allo-BMT)或外周血干细胞移植治疗FHL或耐化疗的LAHS或EBV-AHS病例,优于常规化疗和免疫抑制治疗。,肿瘤相关性噬血细胞综合征治疗方案决定于疾病的类型,如HPS发生于治疗前的免疫缺陷患者,则治疗主要是抗感染及抗肿瘤;如果HPS发生于化疗后,而肿瘤已缓解则应停止抗肿瘤治疗,同时抗感染,加用肾上腺皮质激素及VP16;对进展迅速的MAHS则应针对细胞因子所致的损害进行治疗,可用前述HLH94方案。,NewtherapeuticapproachesAsanalternativeapproachtoetoposide-basedapproaches,ATG/prednisonehavebeenused.54Althoughasignificantnumberofpatientsfailtorespondadequatelyorcompletelytoetoposide-basedregimens,ATG-basedregimensarecomplicatedbyrelativelyfrequentandearlyrelapse;mediantimetorelapsereportedbyOuachee-Chardinetalwas5.5weeks.54Thus,arationalcombinationoftheseapproachesmayimproveoutcomesbyincreasinginitialresponsesandmaintainingthemuntilHCTcanbeobtained.Currently,amulticenterclinicaltrial,HybridImmunotherapyforHLHisunderwayinNorthAmerica(/ct2/show/NCT01104025).Inthisapproach,ATGandetoposideareincorporatedintooneregimen,buttheetoposidedoseintensityisdecreasedtominimizepotentialmyelosuppression.,AlthoughHLHappearstobeadiseaseofexcessiveimmuneactivation,theidealformofimmunesuppression/anti-inflammatorytherapyremainsunknown.Althoughsomewhatresponsivetocorticosteroidsandclearlyresponsivetoetoposideoranti-T-cellserotherapy(ATGoralemtuzumab),HLHremainsdifficulttotreat.Inthefuture,avarietyofrationallydesignedimmunosuppressiveagentsarelikelytocomeintoclinicalusefortransplantationorautoimmunedisorders.Someoftheseagentsmayalsoprovetobeusefulforthetreatment

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论